饶云霞,张申华,杨艳华,艾文娟,刘建华,马元玉.戊酸雌二醇与坤宁安丸对更年期综合征女性激素水平及免疫功能的影响[J].,2017,17(1):119-122 |
戊酸雌二醇与坤宁安丸对更年期综合征女性激素水平及免疫功能的影响 |
Effects of Estradiol Valerate Combined with Kunningan Pill on the Serum Hormones Levels and Immune Function of Patients with Climacteric Syndrome |
投稿时间:2016-08-01 修订日期:2016-08-23 |
DOI:10.13241/j.cnki.pmb.2017.01.030 |
中文关键词: 戊酸雌二醇 坤宁安丸 更年期综合征 免疫功能 |
英文关键词: Estradiol valerate Kunningan Pill Climacteric syndrome Immune function |
基金项目:湖北省自然科学基金项目(SJ970572) |
|
摘要点击次数: 872 |
全文下载次数: 1028 |
中文摘要: |
摘要 目的:探讨戊酸雌二醇联合坤宁安丸对女性更年期综合征患者血清激素水平及免疫功能影响。方法:收集我院就诊或住院治疗的120例更年期综合征患者,随机分为实验组和对照组,每组60例。对照组患者给予戊酸雌二醇治疗,实验组患者在对照组基础上给予坤宁安丸治疗。分别于治疗前后对患者血清卵泡刺激素(FSH)、雌二醇(E2)、CD3+、CD4+、CD8+水平及Kupperman评分、临床疗效进行检测并比较。结果:与治疗前相比,治疗后两组患者的FSH、CD8+、KI评分水平均下降(P<0.05),E2、CD3+CD4+水平均升高(P<0.05);与对照组相比,实验组患者的FSH、CD8+、KI评分水平较低(P<0.05),E2、CD3+、CD4+水平较高,临床治疗总有效率较高(P<0.05)。结论:戊酸雌二醇联合坤宁安丸能够升高更年期综合征患者血清E2水平,降低FSH水平,并提高患者的免疫功能,临床疗效较好。 |
英文摘要: |
ABSTRACT Objective: To investigate the estradiol valerate combined Kunningan Pill on serum hormone level and immune func- tions in patients with climacteric syndrome. Methods: 120 cases of menopausal syndrome in our hospital were selected and randomly di- vided into the experiment group and the control group with 60 cases in each group. The control group were treated with estradiol valerate tablets 1 mg/time, 1 times/d; the patients in the experiment group were given Kunningan Pill based on the control group, 3 g/time, 3 times/d, oral. Treatment for 8 consecutive weeks. After the treatment, the serum follicle stimulating hormone (FSH), estradiol (E2), CD3+, CD4+, CD8+, Kupperman score and the clinical efficacy of patients were detected and compared. Results: Compared with before treat- ment, the FSH, CD8+, Ki score levels decreased (P<0.05), E2, CD3+, CD4+ levels were significantly increased (P<0.05) after treatment of two groups of patients; compared with the control group, FSH, CD8+, Ki score levels were lower (P<0.05), E2, CD3+, CD4+ levels were higher, clinical treatment of total efficiency was higher (P<0.05) Conclusion: Estradiol valerate combined Kunningan Pill can increased menopausal syndrome patients, the level of serum E2, reduce FSH levels, enhance the immune function and the clinical. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |
|
|
|